TY - JOUR
TI - COST-UTILITY AND BUDGET IMPACT ANALYSIS OF CERTOLIZUMAB PEGOL PLUS
METHOTREXATE FOR THE TREATMENT OF MODERATE-TO-SEVERE ACTIVE RHEUMATOID
ARTHRITIS IN GREECE
AU - Maniadakis, N.
AU - Boumpas, D.
AU - Kourlaba, G.
AU - Christou, P. and
AU - Anargiros, I
AU - Smets, E.
AU - Purcaru, O.
JO - Value in Health
PY - 2011
VL - 14
TODO - 7
SP - A310
PB - EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
SN - 1098-3015, 1524-4733
TODO - 10.1016/j.jval.2011.08.431
TODO - null
TODO - null
ER -